2008•Zhongguo xin yao zazhiRequires access

Preparation of tramadol hydrochloride controlled-release tablets and evaluation of its bioavailability in dogs

Qiang Li

Open publisher page 0 citations

Abstract

Objective:To prepare tramadol hydrochloride controlled-release tablets and to evaluate its relative bioavailability in dogs.Methods:Tramadol hydrochloride controlled-release tablets were prepared with cellulose acetate as coating materials,polyethylene glycol 400 as pore-forming agents.In a randomized,crossover,and single-dose study,the tramadol concentration in dog plasma was measured by HPLC after an oral administration of 200 mg commercial conventional tablets or controlled-release tablets.Results:The pharmacokinetic parameters were as follows,AUC0~∞(10 230.6±2 312.1) and(10 808.8±1 794.3)ng·h·mL-1,Cmax(1 670.6±252.3) and(812.7±94.3)ng·mL-1,Tmax(2.0±0.4) and(7.5±1.9) h,for conventional and controlled-release tablets respectively.Conclusion:Tramadol hydrochloride controlled-release tablets had well controlled-release characteristics in vivo,and the relative bioavailability was(107.0±8.2)%.Furthermore,the correlation of pharmacokinetics in vivo and release in vitro was good for controlled-release tablets.

About this research paper

What this paper is about

Objective:To prepare tramadol hydrochloride controlled-release tablets and to evaluate its relative bioavailability in dogs.Methods:Tramadol hydrochloride controlled-release tablets were prepared with cellulose acetate as coating materials,polyethylene glycol 400 as pore-forming agents.In a randomized,crossover,and single-dose study,the tramadol concentration in dog plasma was measured by HPLC after an oral administration of 200 mg commercial conventional tablets or controlled-release tablets.Results:The pharmacokinetic parameters were as follows,AUC0~∞(10 230.6±2 312.1) and(10 808.8±1 794.3)ng·h·mL-1,Cmax(1 670.6±252.3) and(812.7±94.3)ng·mL-1,Tmax(2.0±0.4) and(7.5±1.9) h,for conventional and controlled-release tablets respectively.Conclusion:Tramadol hydrochloride controlled-release tablets had well controlled-release characteristics in vivo,and the relative bioavailability was(107.0±8.2)%.Furthermore,the correlation of pharmacokinetics in vivo and release in vitro was good for controlled-release tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To prepare tramadol hydrochloride controlled-release tablets and to evaluate its relative bioavailability in dogs.Methods:Tramadol hydrochloride controlled-release tablets were prepared with cellulose acetate as coating materials,polyethylene glycol 400 as pore-forming agents.In a randomized,crossover,and single-dose study,the tramadol concentration in dog plasma was measured by HPLC after an oral administration of 200 mg commercial conventional tablets or controlled-release tablets.Results:The pharmacokinetic parameters were as follows,AUC0~∞(10 230.6±2 312.1) and(10 808.8±1 794.3)ng·h·mL-1,Cmax(1 670.6±252.3) and(812.7±94.3)ng·mL-1,Tmax(2.0±0.4) and(7.5±1.9) h,for conventional and controlled-release tablets respectively.Conclusion:Tramadol hydrochloride controlled-release tablets had well controlled-release characteristics in vivo,and the relative bioavailability was(107.0±8.2)%.Furthermore,the correlation of pharmacokinetics in vivo and release in vitro was good for controlled-release tablets.

Key concepts: Bioavailability, Tramadol Hydrochloride, Cmax, Controlled release, Pharmacokinetics, Ethyl cellulose, Chemistry, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of tramadol hydrochloride controlled-release tablets and evaluation of its bioavailability in dogs — Research Paper | ScholarLens